高速液体クロマトグラフィーによるメキシレチンの血清中濃度測定およびその蛋白結合率

概要

論文の詳細を見る
A new method to determine serum mexiletine (MX) concentrations using high-performance liquid chromatography (HPLC) was established. This method could reduce a sample volume to 100μl of serum and could shorten the pretreatment time to less than 10 minutes by using Chem Elut minicolumn. The results obtained by this method (n=28) correlated well with those obtained by gas chromatography method (r=0.997). Moreover, this method had a good recovery and reproducibility, suggesting that it is an excellent method for determining serum MX concentrations. Using this HPLC method, serum protein binding of MX was studied in healthy subjects and patients with chronic renal failure (CRF). The protein binding of MX was 60.83±4.37% in healthy subjects (n=6) and 52.45±6.22% in CRF (n=9). The protein binding of MX in CRF was significantly decreased, compared with healthy subjects, indicating an apparent elevation of free drug concentrations. In general, dose adjustment of MX in CRF is considered to be unnecessary. However, free drug concentrations may participate in the appearance of effects and adverse reactions. The possibility of enhanced pharmacological effects and increased adverse reactions due to such variations of protein binding in CRF should be also considered.
日本医療薬学会の論文
1992-10-20